• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 90 of 100
General Views of Eli Lilly & Co.
HealthWhy drug maker Eli Lilly’s stock price is down big today
By John KellOctober 12, 2015
Hedge fund manager Bill Ackman
FinanceThe strange thing about Bill Ackman’s defense of Valeant’s drug prices
By Stephen GandelOctober 7, 2015
AmerisourceBergen pays $2.58 billion to buy PharMEDium
HealthAmerisourceBergen pays $2.58 billion to buy PharMEDium
By Laura LorenzettiOctober 6, 2015
Symbolic - biotechnology - genetic engineering
HealthTPP trade deal: Even more bad news for biotech industry
By Laura LorenzettiOctober 5, 2015
Japan Scenics
HealthThis Japanese pufferfish could be the ultimate painkiller
By Laura LorenzettiSeptember 30, 2015
Why drug price controversy is great news for this hedge fund manager
FinanceWhy drug price controversy is great news for this hedge fund manager
By Jen WiecznerSeptember 30, 2015
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
HealthThe drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
By Laura LorenzettiSeptember 29, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
HealthBiotech stocks dive as lawmakers take aim at Valeant for drug price hikes
By Laura LorenzettiSeptember 28, 2015
GOP Candidate For President Donald Trump Campaigns In Columbia, South Carolina
LeadershipDonald Trump on drug price-raising CEO: ‘Spoiled brat’
By Laura LorenzettiSeptember 24, 2015
Inside Teva Pharmaceuticals Headquarters
HealthHere are the 5 drug classes with the biggest price gains
By Laura LorenzettiSeptember 23, 2015
MSMB Capital Management CIO Martin Shkreli
HealthTuring backs down on Daraprim drug pricing
By TIMESeptember 23, 2015
157934085
HealthDoctors respond to Turing drug price hike: ‘It’s scare mongering’
By Laura LorenzettiSeptember 22, 2015
HIllary Rodham Clinton
HealthHillary Clinton releases health plan that aims to combat skyrocketing drug costs
By Laura LorenzettiSeptember 22, 2015
MSMB Capital Management CIO Martin Shkreli
HealthHere’s why Turing Pharmaceuticals says 5,000% price bump is necessary
By Laura LorenzettiSeptember 21, 2015
Picture taken on January 15, 2012 in Lil
HealthThis 62-year-old drug just got 5,000% more expensive
By Laura LorenzettiSeptember 21, 2015
1...
  • 88
  • 89
  • 90
  • 91
  • 92
...100
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Investing
Mark Cuban admits he made a mistake letting go of the Mavericks: 'I don't regret selling. I regret who I sold to'placeholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.